The long-term prognosis of lupus nephritis patients treated with intravenous cyclophosphamide.

Matsuyama, Naomi; Morimoto, Shinji; Tokano, Yoshiaki; Amano, Hirofumi; Nozawa, Kazuhisa; Isonuma, Hiroshi; Hashimoto, Hiroshi; Takasaki, Yoshinari

Matsuyama, Naomi; Morimoto, Shinji; Tokano, Yoshiaki; Amano, Hirofumi; Nozawa, Kazuhisa; Isonuma, Hiroshi; Hashimoto, Hiroshi; Takasaki, Yoshinari.

Affiliation

Matsuyama N; Department of General Medicine, Juntendo University, School of Medicine, Tokyo. 0120981501@jcom.home.ne.jp

Intern Med ; 49(9): 823-8, 2010.

Article in En | MEDLINE | ID: mdl-20453401

Subject(s)

Cyclophosphamide/therapeutic use; Immunosuppressive Agents/therapeutic use; Lupus Nephritis/drug therapy; Lupus Nephritis/mortality; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Lupus Nephritis/diagnosis; Male; Probability; Prognosis; Retrospective Studies; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Survival Rate; Time; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Lupus Nephritis / Cyclophosphamide / Immunosuppressive Agents Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Intern Med Journal subject: MEDICINA INTERNA Year: 2010 Document type: Article Country of publication: Japan

Search on Google

Add to My VHL

XML

PubMed Links